Poliovirus vaccination: Current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis

Expert Reviews in Molecular Medicine

Volumn 1, Issue 13, 1999, Pages 1-17

  Minor, Philip D ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

eradication; molecular biology; pathogenesis; polio; poliomyelitis; poliovirus; vaccine

Indexed keywords

EID: 85012554374     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399499000848     Document Type: Article

References (23)

1. Paul, J.R. (1971) A History of Poliomyelitis. Yale University Press, New Haven, USA
2. Landsteiner, K. and Popper, E. (1909) Ubertragung der Poliomyelitis acuta auf Affen. Z Immunitatsforsh exp Ther 2, 377–390
3. Kling, C., Wernstedt, W. and Pettersen, A. (1912) Recherches sur le mode de propagation de la paralysie infantile epidemique. Z Immunitatsforsch 12, 316–323 (part 1); 657–670 (part 2)
4. Minor, P.D. (1997) Poliovirus. In Viral Pathogenesis (Nathanson, N. et al., eds), pp. 555–574, Lippincott-Raven, Philadelphia, NY, USA
5. Flexner, S. and Clarek, P.F. (1912) A note on the mode of infection in epidemic poliomyelitis. Proc Soc Exp Biol Med 10, 1–2
6. Bodian, D. (1955) Emerging concept of poliomyelitis infection. Science 122, 105–108
7. Sabin, A.B. (1956) Pathogenesis of poliomyelitis: reappraisal in the light of new data. Science 123, 1151–1157
8. Hammon, W.D. et al. (1953) Evaluation of Red Cross gammaglobulin as a prophylactic agent for poliomyelitis. 4. A final report of results based on clinical diagnosis. JAMA 151, 1272–1285
9. Sabin, A.B. and Boulger, L. (1973) History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1, 115–118
10. Nkowane, B.M. et al. (1987) Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 257, 1335–1340, PubMed ID:87141492
11. Minor, P.D. (1992) The molecular biology of poliovaccines. J Gen Virol 73, 3065–3077, PubMed ID:93107840
12. Westrop, G.D. et al. (1989) Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol 63, 1338–1344, PubMed ID:89125728
13. Ren, R.B., Moss, E.G. and Racaniello, V.R. (1991) Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol 65, 1377–1382, PubMed ID:91140729
14. Macadam, A.J. et al. (1993) Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192, 18–26, PubMed ID:93297104
15. Bouchard, M.J., Lam, D.H. and Racaniello, V.R. (1995) Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 69, 4972–4978, PubMed ID:95333278
16. Minor, P.D. et al. (1986) Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67, 693–706, PubMed ID:86170417
17. Dunn, G. et al. (1990) Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol 32, 92–95, PubMed ID:91124004
18. Le, S.Y. and Zuker, M. (1990) Common structures of the 5′ non-coding RNA in enteroviruses and rhinoviruses. Thermodynamical stability and statistical significance. J Mol Biol 216, 729–741, PubMed ID:91080160
19. Minor, P.D. et al. (1989) The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol 70, 1117–1123, PubMed ID:89279287
20. Nottay, B.K. et al. (1981) Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 108, 405–423, PubMed ID:81127988
21. Magrath, D.I. et al. (1986) Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. J Gen Virol 67, 899–905, PubMed ID:86198629
22. MacCallum, F.O. (1971) Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia. Spec Rep Ser Med Res Counc 310, 72–85, PubMed ID:71183302
23. Filman, D.J. et al. (1989) Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 8, 1567–1579, PubMed ID:89356627